Fidelity International’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.59M | Sell |
39,726
-46,686
| -54% | -$4.28M | ﹤0.01% | 723 |
|
|
2025
Q4 | $7.77M | Buy |
86,412
+55,400
| +179% | +$5.25M | 0.01% | 617 |
|
|
2025
Q3 | $3.05M | Buy |
+31,012
| New | +$3.07M | ﹤0.01% | 693 |
|
|
2024
Q4 | – | Sell |
-9,138
| Closed | -$986K | – | 986 |
|
|
2024
Q3 | $986K | Buy |
+9,138
| New | +$997K | ﹤0.01% | 729 |
|
|
2021
Q4 | – | Sell |
-292,044
| Closed | -$41.5M | – | 862 |
|
|
2021
Q3 | $41.5M | Sell |
292,044
-507,787
| -63% | -$74.7M | 0.05% | 325 |
|
|
2021
Q2 | $125M | Sell |
799,831
-130,770
| -14% | -$21.2M | 0.13% | 178 |
|
|
2021
Q1 | $145M | Buy |
930,601
+3,737
| +0.4% | +$579K | 0.16% | 155 |
|
|
2020
Q4 | $139M | Buy |
926,864
+296,959
| +47% | +$41.9M | 0.17% | 148 |
|
|
2020
Q3 | $83.3M | Buy |
629,905
+320,466
| +104% | +$41.9M | 0.1% | 210 |
|
|
2020
Q2 | $35.9M | Buy |
+309,439
| New | +$35.7M | 0.05% | 300 |
|
|
2020
Q1 | – | Sell |
-260,343
| Closed | -$37.8M | – | 1027 |
|
|
2019
Q4 | $37.8M | Buy |
260,343
+5,037
| +2% | +$695K | 0.05% | 295 |
|
|
2019
Q3 | $34M | Buy |
255,306
+175,298
| +219% | +$22.6M | 0.05% | 298 |
|
|
2019
Q2 | $9.15M | Buy |
80,008
+8,214
| +11% | +$962K | 0.01% | 478 |
|
|
2019
Q1 | $8.9M | Buy |
+71,794
| New | +$8.16M | 0.01% | 456 |
|
|
2018
Q4 | – | Sell |
-4
| Closed | -$1K | – | 1000 |
|
|
2018
Q3 | $1K | Buy |
+4
| New | +$476 | ﹤0.01% | 900 |
|
|
2017
Q4 | – | Sell |
-307,455
| Closed | -$35M | – | 532 |
|
|
2017
Q3 | $35M | Sell |
307,455
-478,838
| -61% | -$55.3M | 0.1% | 185 |
|
|
2017
Q2 | $98M | Sell |
786,293
-125,248
| -14% | -$14.8M | 0.28% | 101 |
|
|
2017
Q1 | $108M | Buy |
911,541
+217,495
| +31% | +$24.7M | 0.3% | 93 |
|
|
2016
Q4 | $69.5M | Buy |
694,046
+455,085
| +190% | +$48.8M | 0.2% | 119 |
|
|
2016
Q3 | $30.2M | Sell |
238,961
-51,100
| -18% | -$6.31M | 0.09% | 188 |
|
|
2016
Q2 | $33.9M | Sell |
290,061
-30,541
| -10% | -$3.46M | 0.11% | 179 |
|
|
2016
Q1 | $33.2M | Sell |
320,602
-234,217
| -42% | -$22.7M | 0.1% | 183 |
|
|
2015
Q4 | $55.3M | Buy |
554,819
+7,762
| +1% | +$759K | 0.17% | 133 |
|
|
2015
Q3 | $49.9M | Buy |
+547,057
| New | +$54.8M | 0.17% | 133 |
|
|
2014
Q3 | – | Sell |
-228,660
| Closed | -$23.1M | – | 504 |
|
|
2014
Q2 | $23.1M | Sell |
228,660
-617,898
| -73% | -$60.3M | 0.09% | 227 |
|
|
2014
Q1 | $77.7M | Buy |
846,558
+9,308
| +1% | +$858K | 0.28% | 94 |
|
|
2013
Q4 | $75.8M | Buy |
837,250
+135,394
| +19% | +$11.7M | 0.31% | 91 |
|
|
2013
Q3 | $56M | Buy |
701,856
+495,856
| +241% | +$39M | 0.27% | 102 |
|
|
2013
Q2 | $15M | Buy |
+206,000
| New | +$15.4M | 0.08% | 225 |
|
Other funds holding ZBH
VCM
VPM
Fidelity International's ZBH Position: Q1 2026 in Review
Fidelity International reduced its Zimmer Biomet (ZBH) stake by 54% in Q1 2026, selling an estimated $4.28M and leaving 39,726 shares worth $3.59M. The position accounts for ﹤0.01% of the portfolio, ranked #723.
Fidelity International first reported a position in ZBH in Q2 2013 and has held it in 29 quarters since. The position peaked at $145M in Q1 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Fidelity International held 39,726 shares of Zimmer Biomet worth $3.59M as of Q1 2026.
- Fidelity International sold 46,686 Zimmer Biomet shares in Q1 2026, an estimated $4.28M.
- Zimmer Biomet made up ﹤0.01% of Fidelity International's portfolio in Q1 2026, its #723 holding.
- Fidelity International first reported a position in Zimmer Biomet in Q2 2013 and has held it in 29 quarters since.
- Fidelity International's Zimmer Biomet position peaked at $145M in Q1 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.